Pharma's Almanac
Pharma's Almanac, a leading publication in the pharmaceutical and biotechnology sectors, is headquartered in the United States. Established to provide insights and analysis, it serves a global audience, focusing on key operational regions across North America and Europe. Since its inception, Pharma's Almanac has become a trusted resource for industry professionals, offering in-depth articles, expert interviews, and market trends. The publication's core offerings include comprehensive reports on drug development, manufacturing processes, and regulatory updates, distinguishing itself through its commitment to high-quality, data-driven content. With a strong market position, Pharma's Almanac has achieved notable recognition for its contributions to industry knowledge, making it an essential tool for stakeholders seeking to navigate the complexities of the pharmaceutical landscape.
DitchCarbon Score
How does Pharma's Almanac's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharma's Almanac's score of 3 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharma's Almanac's reported carbon emissions
Pharma's Almanac currently does not provide specific carbon emissions data, as there are no available figures for recent years. Consequently, there are no reported emissions in kg CO2e, nor are there defined reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that Pharma's Almanac may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Pharma's Almanac to establish clear emissions reduction strategies and publicly commit to measurable climate goals to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharma's Almanac is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
